Cargando…
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
CRISPR-mediated genome editing of primary human lymphocytes is typically carried out via electroporation, which can be cytotoxic, cumbersome and costly. Here we show that the yields of edited primary human lymphocytes can be increased substantially by delivering a CRISPR ribonucleoprotein mixed with...
Autores principales: | Foss, Dana V., Muldoon, Joseph J., Nguyen, David N., Carr, Daniel, Sahu, Srishti U., Hunsinger, John M., Wyman, Stacia K., Krishnappa, Netravathi, Mendonsa, Rima, Schanzer, Elaine V., Shy, Brian R., Vykunta, Vivasvan S., Allain, Vincent, Li, Zhongmei, Marson, Alexander, Eyquem, Justin, Wilson, Ross C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129304/ https://www.ncbi.nlm.nih.gov/pubmed/37147433 http://dx.doi.org/10.1038/s41551-023-01032-2 |
Ejemplares similares
-
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies
por: Goodman, Daniel B., et al.
Publicado: (2022) -
NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting
por: Tan, Corey, et al.
Publicado: (2020) -
CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells
por: Lin-Shiao, Enrique, et al.
Publicado: (2022) -
Negative feedback by NUR77/Nr4a1 restrains B cell clonal dominance during early T-dependent immune responses
por: Brooks, Jeremy F., et al.
Publicado: (2021) -
Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms
por: Baik, Ron, et al.
Publicado: (2021)